Insider · CIK 0001376847

O'Connor Daniel J.

Reports to the SEC for 8 companies · MINNEAPOLIS, MN

sec.gov

Transactions

Companies

Filings

CIK

0001376847

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-01	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+40.4K sh	—	—	40,412
2025-02-20	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+64.2K sh	—	—	64,242
2024-03-07	Ambrx Biopharma, Inc.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−48.2K sh	—	—	0
2024-03-07	Ambrx Biopharma, Inc.Restricted Stock UnitsD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−295K sh	—	—	0
2024-03-07	Ambrx Biopharma, Inc.Restricted Stock UnitsD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−750K sh	—	—	0
2024-03-07	Ambrx Biopharma, Inc.Option to Purchase Common StockD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−773K sh	—	—	0
2024-03-07	Ambrx Biopharma, Inc.Option to Purchase Common StockD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−174K sh	—	—	0
2024-01-04	SEELOS THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+1,666 sh	—	—	1,666
2023-12-11	Ambrx Biopharma, Inc.A Award	Director, President and CEO	AAward	+750K sh	—	—	1,363,332
2023-10-27	Ambrx Biopharma, Inc.S Sale	Director, President and CEO	SSale	−50K sh	$9.82	−$491K	342,845
2023-07-05	Ambrx Biopharma Cayman, Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+1.22M sh	—	—	1,216,500
2023-04-26	Ambrx Biopharma Cayman, Inc.A Award	Director, President and CEO	AAward	+2.75M sh	—	—	2,750,000
2023-01-05	SEELOS THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2022-12-12	ZVSAZyVersa Therapeutics, Inc.J Other	Director, 10% Owner	JOther	+1.38M sh	—	—	1,377,598
2022-12-12	ZVSAZyVersa Therapeutics, Inc. · Series A Convertible Preferred StockJ Other	Director, 10% Owner	JOther	+1,750 sh	—	—	1,750
2022-12-12	ZVSAZyVersa Therapeutics, Inc. · Warrant (right to buy)J Other	Director, 10% Owner	JOther	+1,750 sh	—	—	1,750
2022-12-12	ZVSAZyVersa Therapeutics, Inc. · Warrant (right to buy)J Other	Director, 10% Owner	JOther	+177K sh	—	—	177,204
2022-06-01	SEELOS THERAPEUTICS, INC.P Purchase	Director	PPurchase	+16K sh	$0.61	+$9,788.8	16,000
2022-01-06	ZVSAZyVersa Therapeutics, Inc.J Other	Director, 10% Owner	JOther	+42K sh	—	—	42,005
2022-01-06	ZVSAZyVersa Therapeutics, Inc. · Class B common stockJ Other	Director, 10% Owner	JOther	−23.4K sh	—	—	201,239
2022-01-06	ZVSAZyVersa Therapeutics, Inc. · Class B common stockJ Other	Director, 10% Owner	JOther	+609 sh	—	—	201,848
2022-01-05	SEELOS THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2021-04-30	ONCOSEC MEDICAL IncS Sale	Director, CEO and President	SSale	−3,172 sh	$4.86	−$15.4K	96,097
2021-02-01	ONCOSEC MEDICAL IncS Sale	Director, CEO and President	SSale	−3,413 sh	$7.71	−$26.3K	99,269
2021-01-06	SEELOS THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2020-11-02	ONCOSEC MEDICAL IncS Sale	Director, CEO and President	SSale	−3,280 sh	$3.79	−$12.4K	102,682
2020-08-24	ONCOSEC MEDICAL IncStock Option (Right to Buy)A Award	Director, CEO and President	AAward	+152K sh	—	—	152,000
2020-07-31	ONCOSEC MEDICAL IncS Sale	Director, CEO and President	SSale	−3,133 sh	$4.20	−$13.2K	105,962
2020-05-29	ONCOSEC MEDICAL IncA Award	Director, CEO and President	AAward	+90.6K sh	—	—	153,566
2020-05-29	ONCOSEC MEDICAL IncF Tax Payment	Director, CEO and President	FTax Payment	−44.5K sh	$2.23	−$99.2K	109,095
2020-05-29	ONCOSEC MEDICAL IncStock Option (Right to Buy)A Award	Director, CEO and President	AAward	+304K sh	—	—	304,000
2020-04-30	ONCOSEC MEDICAL IncS Sale	Director, CEO and President	SSale	−3,075 sh	$1.79	−$5,504.25	62,986
2020-01-31	ONCOSEC MEDICAL IncS Sale	Director, CEO and President	SSale	−2,654 sh	$1.96	−$5,201.84	66,061
2020-01-06	SEELOS THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2019-10-31	ONCOSEC MEDICAL IncS Sale	Director, CEO and President	SSale	−2,128 sh	$2.16	−$4,596.48	68,715
2019-07-31	ONCOSEC MEDICAL IncF Tax Payment	Director, CEO and President	FTax Payment	−2,156 sh	$2.23	−$4,807.88	70,843
2019-04-30	ONCOSEC MEDICAL IncF Tax Payment	Director, CEO and President	FTax Payment	−21.4K sh	$0.56	−$12.1K	729,992
2019-03-20	SEELOS THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+24K sh	—	—	24,000
2019-03-20	SEELOS THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2019-01-31	ONCOSEC MEDICAL IncF Tax Payment	Director, CEO and President	FTax Payment	−25.3K sh	$0.88	−$22.3K	751,349
2018-12-24	ONCOSEC MEDICAL IncA Award	Director, CEO and President	AAward	+750K sh	—	—	776,667
2018-11-07	ONCOSEC MEDICAL IncP Purchase	Director, CEO and President	PPurchase	+10K sh	$0.91	+$9,100	26,667
2018-05-03	ONCOSEC MEDICAL IncStock Option (Right to Buy)A Award	Director, CEO and President	AAward	+250K sh	$1.47	+$368K	2,850,000
2018-02-05	ONCOSEC MEDICAL IncP Purchase	Director, CEO and President	PPurchase	+16.7K sh	$1.50	+$25K	16,667
2018-01-12	ONCOSEC MEDICAL IncStock Option (Right to Buy)A Award	Director, CEO and President	AAward	+2M sh	—	—	2,000,000
2018-01-12	ONCOSEC MEDICAL IncStock Option (Right to Buy)A Award	Director, CEO and President	AAward	+500K sh	—	—	500,000
2017-09-07	ONCOSEC MEDICAL IncStock Option (Right to Buy)A Award	Director, CEO and President	AAward	+100K sh	—	—	100,000
2017-06-30	Ayala Pharmaceuticals, Inc.A Award	Director, Chief Executive Officer	AAward	+742 sh	$6.49	+$4,815.58	618,352
2017-06-19	Ayala Pharmaceuticals, Inc.A Award	Director, Chief Executive Officer	AAward	+177K sh	—	—	617,610
2017-05-31	Ayala Pharmaceuticals, Inc.A Award	Director, Chief Executive Officer	AAward	+421 sh	$8.07	+$3,397.47	440,508

Recent filings

Accepted (ET)
Jun 34
O'Connor Daniel J.0001376847-26-000002
SEC(opens sec.gov)
Feb 244
O'Connor Daniel J.0001235802-25-000012
SEC(opens sec.gov)
Mar 74
O'Connor Daniel J.0000950170-24-028190
SEC(opens sec.gov)
Jan 84
O'Connor Daniel J.0001104659-24-002383
SEC(opens sec.gov)
Dec 114
O'Connor Daniel J.0000950170-23-069446
SEC(opens sec.gov)
Oct 314
O'Connor Daniel J.0000950170-23-056943
SEC(opens sec.gov)
Jul 74
O'Connor Daniel J.0000950170-23-032232
SEC(opens sec.gov)
Apr 284
O'Connor Daniel J.0001209191-23-026093
SEC(opens sec.gov)
Jan 54
O'Connor Daniel J.0001136261-23-000007
SEC(opens sec.gov)
Dec 144
O'Connor Daniel J.0001493152-22-035477
SEC(opens sec.gov)
Jun 24
O'Connor Daniel J.0001136261-22-000249
SEC(opens sec.gov)
Mar 104
O'Connor Daniel J.0001213900-22-011644
SEC(opens sec.gov)

Companies

Address

301 CARLSON PARKWAY SUITE 210

MINNEAPOLIS, MN, 55305